Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06).
Journal for immunotherapy of cancer | 2024-03-13 | PMID 38485184
Kim Ju Won, Lee Hyo Jin, Lee Ji Yoon and 13 more
